This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

"Do You Dare?": Dental Product Launch Is Model For Cross-Media Integration

CHICAGO, April 5, 2013 /PRNewswire/ -- To sell dental products today, you need to reach dentists where they're ready to learn. That's why DENTSPLY Caulk and Symmetri Marketing Group made the TPH Spectra launch campaign a model of cross-channel integration.

DENTSPLY Caulk is one of the world's largest dental products suppliers, and TPH Spectra is its newest universal composite for restorations. The launch is energized by the TPH Spectra "Truth Or Dare" Challenge – blind tests comparing the handling of TPH Spectra with competitors.

Dentists are hesitant to switch to new materials; to encourage crucial sampling of TPH Spectra, Symmetri Marketing Group developed print ads and e-mails daring dentists to take the Challenge in-office or at the Chicago Midwinter trade show where TPH Spectra was launched. Many of the dentists who sampled the product agreed to be videotaped – and their surprised reactions to TPH Spectra anchor the new, fully developed and executed by Symmetri.

Extensive Twitter and Facebook integration supported the campaign and site launch, including "participation" by DDS Dan, the fictional dentist/private eye conceived by Symmetri as "spokesman" for an earlier TPH product and now spokesman for multiple DENTSPLY products on Facebook and Twitter, in print and at industry events.

Dentists are strong users of social media, and two large dental distributors asked to participate in TPH Spectra social promotions. For example, Henry Schein reps participated in a Twitter chat with the product manager and DDS Dan.

Symmetri developed an extensive product brochure, but is the foundation. It features quick information, compelling video and a clear CTA. And in line with today's social media, it encourages easy scrolling rather than multiple links for additional information.

The entire campaign is built around an honest proposition. TRUTH: Dentists are hesitant to change. DARE: We dare you to try something new – and a DENTSPLY Caulk rep will help.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.21 -0.44%
FB $117.80 -0.22%
GOOG $701.26 0.80%
TSLA $211.34 -5.00%
YHOO $36.94 2.60%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs